Thomas Templeman - 30 Sep 2022 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Technology Officer
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
30 Sep 2022
Net transactions value
-$22,874
Form type
4
Filing time
13 Jan 2023, 16:47:24 UTC
Previous filing
06 Jul 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Tax liability $22,874 -5,382 -3.8% $4.25 134,868 30 Sep 2022 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
F3 Shares held by the Reporting Person after the reported transaction herein and does not include shares acquired or disposed of in subsequent reported transactions after September 30, 2022.
F4 As of year end December 31, 2022, the Reporting Person held 131,947 shares directly.